$TFX News

Teleflex Announces FDA Breakthrough Device Designation for Freesolve™ Resorbable Magnesium Scaffold

Teleflex Announces Third Quarter 2026 Earnings Conference Call Information

Teleflex Receives FDA Breakthrough Device Designation For Its Freesolve Resorbable Magnesium Scaffold For Percutaneous Coronary Intervention

Truist Securities Maintains Hold on Teleflex, Lowers Price Target to $142

Enrollment Completed in BIOMAG™-LL Clinical Study Evaluating Longer Lengths for Freesolve™ Resorbable Magnesium Scaffold

Teleflex Completes Patient Enrollment In BIOMAG-LL Clinical Study, Evaluating Freesolve RMS In 35 mm And 40 mm Lengths For Treatment Of De Novo Coronary Lesions Up To 38 mm

Full Transcript: Teleflex Q2 2026 Earnings Call

TFX or SONVY: Which Is the Better Value Stock Right Now?

Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ Technology

Teleflex (TFX) Soars 4.4%: Is Further Upside Left in the Stock?

Should New Leadership And Debt Focus At Teleflex (TFX) Require Action From Investors?

Why Teleflex (TFX) Stock Is Trading Up Today

3 Reasons to Avoid TFX and 1 Stock to Buy Instead

Teleflex Growth Prospects, New Leadership Could Drive 2027 Re-Rating, BofA Securities Says

B of A Securities Upgrades Teleflex to Buy from Neutral

B of A Securities Upgrades Teleflex to Buy, Raises Price Target to $158

Teleflex (TFX) Adds A Board Veteran, Is The 19% Undervalued View Enough?

Surgical Equipment & Consumables - Specialty Stocks Q2 Earnings Review: Teleflex (NYSE:TFX) Shines

Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors

Teleflex Features Innovative Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System at CIRSE 2026